Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Warner Huh

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Cancer|August 2, 2016
Expression of p16<sup>INK4A</sup> in cervical precancerous lesions that is unlikely to be preventable by human papillomavirus vaccinesSuguna Badiga, Michelle M Chambers, Warner Huh, et al.
Obstetrics and Gynecology|January 9, 2015
Increased cervical cancer risk associated with screening at longer intervalsWalter Kinney, Thomas C Wright, Helen E Dinkelspiel, et al.
Gynecologic Oncology|February 11, 2015
Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: data from the ATHENA trialJoseph Monsonego, J Thomas Cox, Catherine Behrens, et al.
Gynecologic Oncology|April 22, 2004
Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancerLaura J Havrilesky, Charles A Leath, Warner Huh, et al.
Gynecologic Oncology|September 2, 2008
A phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous A6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancerSharad A Ghamande, Michael H Silverman, Warner Huh, et al.
Gynecologic Oncology|March 16, 2024
An SGO commentary: U.S. News and World Report gynecologic oncology procedural ratings-Do they reflect high-quality care?Amanda N Fader, Emily M Ko, Benjamin D Pollock, et al.
Obstetrics and Gynecology|August 24, 2011
Cervicovaginal cytology in the detection of recurrence after cervical cancer treatmentB J Rimel, Aaron Ferda, Jamie Erwin, et al.
Gynecologic Oncology|July 7, 2015
Comparison of bevacizumab alone or with chemotherapy in recurrent ovarian cancer patientsKatherine C Fuh, Angeles A Secord, Kerri S Bevis, et al.
Tumour Virus Research|May 7, 2022
Human papillomavirus seroprevalence and seroconversion following baseline detection of nine human papillomavirus types in young womenDarron R Brown, Xavier Castellsagué, Daron Ferris, et al.
Gynecologic Oncology|October 18, 2025
Gynecologic oncology fellowship trends: Supply outpacing demand, geographical maldistributionSharonne Holtzman, Evan Myers, Laura J Havrilesky, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Cancer|August 2, 2016
Expression of p16<sup>INK4A</sup> in cervical precancerous lesions that is unlikely to be preventable by human papillomavirus vaccinesSuguna Badiga, Michelle M Chambers, Warner Huh, et al.
Obstetrics and Gynecology|January 9, 2015
Increased cervical cancer risk associated with screening at longer intervalsWalter Kinney, Thomas C Wright, Helen E Dinkelspiel, et al.
Gynecologic Oncology|February 11, 2015
Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: data from the ATHENA trialJoseph Monsonego, J Thomas Cox, Catherine Behrens, et al.
Gynecologic Oncology|April 22, 2004
Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancerLaura J Havrilesky, Charles A Leath, Warner Huh, et al.
Gynecologic Oncology|September 2, 2008
A phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous A6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancerSharad A Ghamande, Michael H Silverman, Warner Huh, et al.
Gynecologic Oncology|March 16, 2024
An SGO commentary: U.S. News and World Report gynecologic oncology procedural ratings-Do they reflect high-quality care?Amanda N Fader, Emily M Ko, Benjamin D Pollock, et al.
Obstetrics and Gynecology|August 24, 2011
Cervicovaginal cytology in the detection of recurrence after cervical cancer treatmentB J Rimel, Aaron Ferda, Jamie Erwin, et al.
Gynecologic Oncology|July 7, 2015
Comparison of bevacizumab alone or with chemotherapy in recurrent ovarian cancer patientsKatherine C Fuh, Angeles A Secord, Kerri S Bevis, et al.
Tumour Virus Research|May 7, 2022
Human papillomavirus seroprevalence and seroconversion following baseline detection of nine human papillomavirus types in young womenDarron R Brown, Xavier Castellsagué, Daron Ferris, et al.
Gynecologic Oncology|October 18, 2025
Gynecologic oncology fellowship trends: Supply outpacing demand, geographical maldistributionSharonne Holtzman, Evan Myers, Laura J Havrilesky, et al.
Pageof 4